Searched for
GENERIC OSELTAMIVIR PHOSPHATE
Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...- On a path to recovery: 4 small pharma stocks with an upside potential of up to 27%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are small and mi...
- Stocks in the news: Bajaj Finance, Tech Mahindra, Paytm, HFCL and Tata PowerBajaj Finance, ICICI Pru Life, L&T Tech, Tata Elxsi, Trident, ICICI Securities, DCM Shriram, Network 18 and Just Dial are among the compani...
- Lupin launches generic influenza treatment capsules in the USThe capsules, in the strengths of 30 mg, 45 mg and 75 mg, are generic versions of Hoffman-La Roche Inc's Tamiflu capsules in the same stren...
- Natco's partner Alvogen gets nod for influenza drug in USIn December last year, Alvogen launched the first generic equivalent to oseltamivir phosphate capsules in the United States.
- Natco Pharma surges 7% on drug approvalThe stock rose 7.33 per cent to hit a high of Rs 650.90 on BSE. Volumes more than doubled on the counter to 98,000 shares, compared with a ...
- Natco Pharma gets ANDA nod for Tamiflu's generic versionTamiflu is used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days.
- Natco settles patent suit with Gilead, others over TamifluNatco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.
- Natco Pharma shares surge over 9 per centThe stock gained sharply by 9.09 per cent to settle at Rs 1,792.05 on the BSE. During the day, it jumped 10.48 per cent to Rs 1,815 -- its ...
- Natco Pharma gets USFDA tentative nod for generic TamifluThe tentative approval of Oseltamivir Phosphate capsules by the US Food and Drug Administration is for multiple strengths of 30mg, 45 mg an...
- Makers of Tamiflu version see share prices surgeShare price of drug companies Ranbaxy, Natco and Strides Acrolabs, that make low-priced versions of anti-flu medicine Tamiflu, surged on Tu...
- Cipla, Ranbaxy in fray to bag govt contract for TamifluDrugmakers Cipla, Ranbaxy, Hetero and Natco are expected to be in the fray to bag the government's contract to buy 20 million low cost anti...
- Indian companies may pitch in with generic version of Tamiflu“We have already received proposals from people on behalf of countries in Latin America, Mexico and Israel. We have the capability to suppl...
- Local drug cos may chip in to treat swine fluThe swine flu outbreak, classified by the World Health Organisation as a “public health emergency of international concern”, may see Indian...
- Ranbaxy to supply oseltamivir capsules to USRanbaxy Laboratories said it was prepared to provide oseltamivir phosphate capsules (generic version of Tamiflu) to the US healthcare syste...
- Ranbaxy to ward off flu by drugsRanbaxy Laboratories on Friday said it was prepared to provide oseltamivir phosphate capsules to the US healthcare system to ward off threa...
- Himanshu Singh to head Travelocity’s India teamTravelocity India has appointed Himanshu Singh as the managing director of India operations.
Load More
